C44.1192

Clinical Causes: Prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds Fair skin that has less melanin, leading to increased susceptibility History of radiation therapy to the skin Age-related changes, as BCC is more common in older individuals Weakened immune system responses Genetic predispositions or family history of skin cancers

Key Symptoms: A shiny, pearly bump or nodule on the eyelid A flat, scaly, or reddish patch that persists or enlarges Rolled edges or a scar-like appearance around the lesion Ulceration or bleeding from the affected area Loss of eyelash or eyelid tissue in severe cases A sore that doesn’t heal or recurs after treatment

Diagnosis Path: Diagnosis typically involves a thorough skin examination by a healthcare professional. Since early skin cancers may resemble benign skin issues, a biopsy is often performed to confirm the presence of carcinoma. Additional tests such as imaging studies may be used if there’s concern about deeper tissue involvement. Proper diagnosis is critical for planning appropriate treatment strategies and assessing whether the cancer has spread or remained localized.

Treatment Protocols: Treatment options for basal cell carcinoma of the eyelid primarily aim to remove the cancer while preserving eyelid function and appearance. These include: - Surgical excision, often with Mohs micrographic surgery, which precisely removes cancerous tissue while conserving healthy tissue - Cryotherapy (freezing the lesion with liquid nitrogen) - Topical treatments, such as 5-fluorouracil or imiquimod, suitable in some cases where lesion size is small - Radiation therapy, generally used when surgery isn’t feasible - Reconstructive procedures to restore eyelid function and aesthetics following removal of the tumor Follow-up care is essential to monitor for any recurrence or new skin lesions, as individuals with BCC have an increased risk of developing additional skin cancers.